S1P1R Modulator Ozanimod (RPC1063) CAS 1306760-87-1

Basic Info

Model No.: 1306760-87-1

Additional Info

Packaging: As required

Productivity: Commercial

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Certificate: Technical Support

Product Description

Ozanimod CAS number is 1306760-87-1, a potential sphingosine 1 receptor agonist for the treatment of multiple sclerosis (MS) and ulcerative colitis, induces peripheral blood lymphocyte isolation, Reduce the number of activated lymphocytes circulating to the gastrointestinal tract. Based on the detailed results of the TOUCHSTONE clinical trial consolidation phase, the trial consolidation data together with previously reported induction data suggests that oral Ozanimod is expected to help patients with moderate to severe ulcerative colitis, and patients in the Ozanimod treatment group, The 32 weeks clinical remission or consolidation rate was significantly higher than the placebo group. The industry is also very optimistic about Ozanimod's business prospects. Although the efficacy of Ozanimod CAS number is 1306760-87-1 has been recognized, there are still some shortcomings. It also needs to be more suitable for the development and production of pharmaceutical preparations through crystal modification and modification.

Thera. Category:Anti-cholinergic

Cas No.:1306760-87-1

Synonyms:Mandelicacid, a-cyclopentyl-,1-methyl-3-pyrrolidinyl ester (6CI,7CI); N-Methyl-3-pyrrolidinylcyclopentylmandelate

NW: 303.396

M.W.:C18H25 N O3

Assay: ≥99%

Packing:Export worthy packing

Material Safety Data Sheet:Available on request